Results 271 to 280 of about 7,543 (282)

Transforaminal lumbar puncture for intrathecal nusinersen administration

Muscle & Nerve, 2018
Adam Evans, Anthony P. Geraci, Michael Jin, Karen Black, Simcha Rimler   +4 more
openaire   +2 more sources

Long-term impact of nusinersen on motor and electrophysiological outcomes in adolescent and adult spinal muscular atrophy: insights from a multicenter retrospective study.

Journal of Neurology
Ningning Wang, Ying Hu, Kexin Jiao, Nachuan Cheng, Jian Sun, JinXue Tang, Jie Song, Chong Sun, Tao Wang, Kai Wang, Kai Qiao, J. Xi, Chongbo Zhao, Liqiang Yu, Wenhua Zhu   +14 more
semanticscholar   +1 more source

Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps

Developmental Medicine and Child Neurology, 2019
Laurent Servais, Laurent Servais
exaly  

Nusinersen im Kindesalter und bei Erwachsenen [PDF]

InFo Neurologie & Psychiatrie, 2018
openaire   +1 more source

Nusinersen in adults with type 3 spinal muscular atrophy: long-term outcomes on motor and respiratory function.

Neurological Sciences
Catarina Serrão, S. Domingues, Catarina Falcão de Campos, S. Moreira, Isabel Conceição, Mamede de Carvalho, M. Oliveira Santos   +6 more
semanticscholar   +1 more source

Cost-effectiveness of Nusinersen for Spinal Muscular Atrophy

JAMA Pediatrics, 2018
openaire   +3 more sources

Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1

Advances in Therapy, 2019
Martin Cloutier, Sue Swaffield
exaly  

Nusinersen: A Treatment for Spinal Muscular Atrophy

Annals of Pharmacotherapy, 2019
Debra L Stevens, Cheri Walker
exaly  

Nusinersen improves walking distance and reduces fatigue in later‐onset spinal muscular atrophy

Muscle and Nerve, 2019
Basil T Darras, Darryl C De Vivo, Eugenio Mercuri   +2 more
exaly  

Nusinersen Found Promising for Spinal Muscular Atrophy

Neurology Today, 2017
openaire   +2 more sources